BLSM BlossomHill Therapeutics, Inc.
Healthcare · Market cap: $445.6M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $25.2M | $0 |
| 2026-Q4 | $0 | $0 |
Bought$25.2M7 buy days
Sold$00 sell days
Net insider flow+$25.2Mnet buying · 5 years
Latest trade2026-08-10GORDON CARL L
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | Buy | GORDON CARL L | Director | 625,000 | $16.00 | $10.0M | 1 |
| 2026-08-10 | Buy | ORBIMED ADVISORS LLC | Director | 625,000 | $16.00 | $10.0M | 1 |
| 2026-08-10 | Buy | Chen Bihua | Director | 312,500 | $16.00 | $5.0M | 1 |
| 2026-08-10 | Buy | Schmid John P. | Director | 6,000 | $16.00 | $96.0K | 1 |
| 2026-08-10 | Buy | Liptak Vincent Paul | General counsel | 2,200 | $16.00 | $35.2K | 1 |
| 2026-08-10 | Buy | Keyes Jason A | CFO | 700 | $16.00 | $11.2K | 1 |
| 2026-08-07 | Buy | Liptak Vincent Paul | General counsel | 2,500 | $15.80 | $39.5K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| GORDON CARL L | Director | $10.0M | $0 | 2026-08-10 |
| ORBIMED ADVISORS LLC | Director | $10.0M | $0 | 2026-08-10 |
| Chen Bihua | Director | $5.0M | $0 | 2026-08-10 |
| Schmid John P. | Director | $96.0K | $0 | 2026-08-10 |
| Liptak Vincent Paul | General counsel | $74.7K | $0 | 2026-08-10 |
| Keyes Jason A | CFO | $11.2K | $0 | 2026-08-10 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-08-07 → 2026-08-10 | 6 | $25.2M | 49 | +33.4% (+31.2% raw) | -9.2% (-11.8% raw) | – | active |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.